Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Ettenberg

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cell Death and Differentiation|February 7, 2004
N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell linesM Cuello, A O Coats, I Darko, et al.
Molecular Cell|January 15, 2000
Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1G Levkowitz, H Waterman, S A Ettenberg, et al.
Leukemia|August 22, 2015
Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myelomaR H Prabhala, M Fulciniti, D Pelluru, et al.
Oncogene|May 10, 2016
Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodiesP Bernasconi-Elias, T Hu, D Jenkins, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cell Death and Differentiation|February 7, 2004
N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell linesM Cuello, A O Coats, I Darko, et al.
Molecular Cell|January 15, 2000
Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1G Levkowitz, H Waterman, S A Ettenberg, et al.
Leukemia|August 22, 2015
Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myelomaR H Prabhala, M Fulciniti, D Pelluru, et al.
Oncogene|May 10, 2016
Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodiesP Bernasconi-Elias, T Hu, D Jenkins, et al.
Pageof 2